FRIDAY, July 23, 2021 (HealthDay News) — Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say. In an earlier survey, more than a third of men with spinal cordContinue Reading

In a HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA’s controversial approval of aducanumab. First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen’s controversial new Alzheimer’s drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.Continue Reading

THURSDAY, July 22, 2021 (HealthDay News) — Black Americans admitted for inpatient hospital care are far more likely than white patients to experience safety-related health complications — even when both are treated in the same facility, a new report warns. And having good insurance didn’t appear to bridge racial differencesContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — To do their best, Olympic athletes need to be both physically and mentally fit, but the COVID-19 pandemic and its restrictions at the Tokyo Olympics has made that a real challenge, experts say. “This Olympics is unprecedented,” said Dr. Michael Lardon, an associateContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — Pfizer’s coronavirus vaccine provides surprisingly robust protection against the highly infectious Delta variant of COVID-19 — but only if you’ve gotten both doses. Fresh data out of England shows that two doses of the messenger RNA (mRNA) vaccine is 88% effective in protectingContinue Reading

Here’s some of HealthDay’s top stories for Thursday, July 22: Two-dose Pfizer vaccine gives great protection against Delta. A new study should reassure millions of Americans who’ve gotten the Pfizer vaccine: Two doses provide 88% protection against the COVID Delta variant. But protection fell sharply for those with only oneContinue Reading